Connect Ovar Coffee cover art

Connect Ovar Coffee

Connect Ovar Coffee

By: OVARCOME
Listen for free

Welcome to the Connect Ovar Coffee Podcast, the show that brings you hope and inspires you to embrace the spirit of OVARCOMING! Each month, we deliver the latest & greatest information on progress and advances in ovarian cancer screening, diagnosis, treatment, and survivorship. Listen. Subscribe. SHARE! THIS is how #WeOvarcome! Let’s Connect Ovar Coffee!Ovarcome Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Dr. Alexander Olawaiye: Inside Platinum Resistant Ovarian Cancer - Actions & Insights
    Apr 13 2026

    Connect Ovar Coffee: Dr. Alexander Olawaiye

    This episode features Dr. Alexander Olawaiye, discussing major advances in ovarian cancer treatment, including the ROSELLA clinical trial.

    Key Highlights:
    1. Ovarian Cancer Challenges:
    - No reliable early screening methods
    - Majority diagnosed at advanced stages (Stage III/IV)
    - Early detection remains a critical unmet need

    2. ROSELLA Trial Breakthrough:
    - Focus on platinum-resistant ovarian cancer
    - Combines relacorilant (a glucocorticoid receptor antagonist) with nab-paclitaxel
    - Demonstrated improved progression-free survival and overall survival
    - No biomarker requirement, making it accessible to more patients

    3. Mechanism of Action:
    - Relacorilant blocks cortisol signaling that promotes chemotherapy resistance
    - Enhances effectiveness of chemotherapy

    4. Safety & Tolerability:
    - No new major toxicities identified
    - Side effects consistent with standard chemotherapy

    5. Clinical Trial Importance:
    - Patients in trials often experience better outcomes
    - Participation helps advance future treatments

    6. Health Equity & Access:
    - Disparities exist in access to care and clinical trials
    - Need to improve awareness, access, and inclusion

    7. Future Outlook:
    - Rapid growth in new treatments over past decade
    - Emerging therapies include antibody-drug conjugates
    - Continued innovation offers hope for patients

    Closing Message:

    Stay informed, consider clinical trials, and remain hopeful as new treatments continue to emerge.


    Show More Show Less
    1 hr and 2 mins
  • Innovative Advances in Ovarian Cancer Care
    Feb 3 2026

    1. Future of Gynecologic Oncology and Clinical Trials
    2. ADCs (antibody drug conjugates) - what we should know
    3. Immunity and Immunotherapy
    4. CAR-T Cell Therapy
    5. Vaccines
    + MORE!
    We discuss on this episode of Connect Ovar Coffee with the Chair of Gynecologic Oncology at Moffitt Cancer Center, Dr. Robert Wenham.
    Learn, Share and Be Empowered 💪.
    Let's #ConnectOvarCoffee

    Show More Show Less
    1 hr and 1 min
  • Transformative Surgical Innovations in Ovarian Cancer: Dr. Pedro Ramirez
    Jan 19 2026

    "You have to feel that you are in the right setting with the right physician who is taking care of YOU personally"

    Connect Ovar Coffee ☕️ 2026 is off to a blazing start with an outstanding chat with our Advisory Board Member and Globally renowned Expert Surgeon, Dr. Pedro Ramirez, Chair of OB-GYN at the Houston Methodist.

    52 minutes of knowledge, information, compassion and candid guidance - share with anyone who may benefit.

    Subscribe. Listen. Learn. Share. Be Empowered! Let's #ConnectOvarCoffee!

    Show More Show Less
    53 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet